Verrica Pharmaceuticals (VRCA)
(Delayed Data from NSDQ)
$5.65 USD
+0.01 (0.09%)
Updated Aug 4, 2025 03:47 PM ET
After-Market: $5.66 +0.02 (0.27%) 4:46 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Verrica Pharmaceuticals Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VRCA 5.65 +0.01(0.09%)
Will VRCA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VRCA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VRCA
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
VRCA: What are Zacks experts saying now?
Zacks Private Portfolio Services
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates
Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now
Other News for VRCA
VRCA Trading Halted: Anticipation Builds for Pending Announcement | VRCA Stock News
Verrica Parmaceuticals trading halted, news pending
12 Health Care Stocks Moving In Thursday's After-Market Session
Verrica Pharmaceuticals (VRCA) Reports Robust Growth in YCANTH Sales
Verrica Pharmaceuticals reports 13,434 YCANTH dispensed applicator units in Q2